Effect of aqueous humor on apoptosis of inflammatory cell types

Investigative Ophthalmology and Visual Science

Volumn 40, Issue 7, 1999, Pages 1418-1426

  D'Orazio, Thomas J ^a   DeMarco, Brendan M ^a   Mayhew, Elizabeth S ^a   Niederkorn, Jerry Y ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL CELL; ANIMAL EXPERIMENT; APOPTOSIS; AQUEOUS HUMOR FLOW; ARTICLE; CELL DEATH; CORNEA ENDOTHELIUM; IMMUNOLOGICAL TOLERANCE; IMMUNOREGULATION; INFLAMMATORY CELL; NONHUMAN; PRIORITY JOURNAL; RABBIT;

ANIMALS; APOPTOSIS; AQUEOUS HUMOR; CELL LINE; CELL SURVIVAL; FLOW CYTOMETRY; KILLER CELLS, LYMPHOKINE-ACTIVATED; MACROPHAGES; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, SCID; NEUTROPHILS; RABBITS; T-LYMPHOCYTES;

EID: 0033009810     PISSN: 01460404     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (48)

1. Kanski JJ. Clinical Ophthalmology. 2nd ed. London: Butterworth; 1989.
2. Kaplan HJ, Streilein JW, Stevens TR. Transplantation immunology of the anterior chamber of the eye, II: immune response to allogeneic cells. J Immunol. 1975;115:805-810.
3. Albert FAJ. Principles and Practice of Ophthalmology: Basic Sciences. Philadelphia: WB Saunders; 1994.
4. Smith RE, Jensen AD, Silverstein AM. Antibody formation by single cells during experimental immunogenic uveitis. Invest Ophthalmol. 1969;8:373-380.
5. Wilbanks GA, Streilein JW. The differing patterns of antigen release and local retention following anterior chamber and intravenous inoculation of soluble antigen: evidence that the eye acts as an antigen depot. Reg Immunol. 1989;2:390-398.
6. Streilein JW, Niederkorn JY. Induction of anterior chamber-associated immune deviation requires an intact, functional spleen. J Exp Med. 1981;153:1058-1067.
7. Granstein RD, Staszewski R, Knisely TL, et al. Aqueous humor contains transforming growth factor-beta and a small (less than 3500 daltons) inhibitor of thymocyte proliferation (published erratum appears in J Immunol 1991;146:3687). J Immunol. 1990; 144:3021-3027.
8. Granstein RD, Staszewski R, Knisely TL, et al. Aqueous humor contains transforming growth factor-beta and a small (less than 3500 daltons) inhibitor of thymocyte proliferation (published erratum appears in J Immunol 1991;146:3687). J Immunol. 1990; 144:3021-3027.
9. Cousins SW, McCabe MM, Danielpour D, Streilein JW. Identification of transforming growth factor-beta as an immunosuppressive factor in aqueous humor. Invest Ophthalmol Vis Sci. 1991;32: 2201-2211.
10. Jiang LQ, Streilein JW. Immune privilege extended to allogeneic tumor cells in the vitreous cavity. Invest Ophtbalmol Vis Sci. 1991;32:224-228.
11. Taylor AW, Streilein JW, Cousins SW. Identification of alpha-melanocyte stimulating hormone as a potential immunosuppressive factor in aqueous humor. Curr Eye Res. 1992;11:1199-1206.
12. Apte RS, Sinha D, Mayhew E, Wistow GJ, Niederkorn JY. Role of macrophage migration inhibitory factor in inhibiting NK cell activity and preserving immune privilege. J Immunol. 1998;160: 5693-5696.
13. Knisely TL, Hosoi J, Nazareno R, Granstein RD. The presence of biologically significant concentrations of glucocorticoids but little or no cortisol binding globulin within aqueous humor: relevance to immune privilege in the anterior chamber of the eye Invest Ophthalmol Vis Sci. 1994;35:3711-3723.
14. Griffith TS, Brunner T, Fletcher SM, Green DR, Ferguson TA. Fas ligand-induced apoptosis as a mechanism of immune privilege (see comments). Science. 1995;270:1189-1192.
15. Griffith TS, Yu X, Herndon JM, Green DR, Ferguson TA. CD95-induced apoptosis of lymphocytes in an immune privileged site induces immunological tolerance. Immunity. 1996;5:7-16.
16. Stuart PM, Griffith TS, Usui N, Repose J, Yu X, Ferguson TA. CD95 ligand (FasL)-induced apoptosis is necessary for corneal allograft survival. J Clin Invest. 1997;99:396-402.
17. Kawashima H, Yamagami S, Tsuru T, Gregerson DS. Anterior chamber inoculation of splenocytes without Fas/Fas-ligand interaction primes for a delayed-type hypersensitivity response rather than inducing anterior chamber-associated immune deviation. Eur J Immunol. 1997;27:2490-2494.
18. Hoffman B, Liebermann DA. Molecular controls of apoptosis: differentiation/growth arrest primary response genes, proto-oncogenes, and tumor suppressor genes as positive and negative modulators. Oncogene. 1994;9:1807-1812.
19. Wyllie AH, Kerr JF, Currie AR. Cell death: the significance of apoptosis. Int Rev Cytol. 1980;68:251-306.
20. Cohen JJ. Apoptosis. Immunol Today. 1993;14:126-130.
21. Kulkarni GV, McCulloch CA. Serum deprivation induces apoptotic cell death in a subset of Balb/c 3T3 fibroblasts. J Cell Sci. 1994; 107:1169-1179.
22. Sellins KS, Cohen JJ. Gene induction by gamma-irradiation leads to DNA fragmentation in lymphocytes. J Immunol. 1987;139:3199-3206.
23. Wyllie AH. Glucocorticoid-induced thymocyte apoptosis is associated with endogenous endonuclease activation. Nature. 1980;284: 555-556.
24. Tata JR, Kawahara A, Baker BS. Prolactin inhibits both thyroid hormone-induced morphogenesis and cell death in cultured amphibian larval tissues. Dev Biol. 1991;146:72-80.
25. Laster SM, Wood JG, Gooding LR. Tumor necrosis factor can induce both apoptic and necrotic forms of cell lysis. J Immunol. 1988;141:2629-2634.
26. Saba JD, Obeid LM. Hannun YA. Ceramide: an intracellular mediator of apoptosis and growth suppression. Philos Trans R Soc Lond B Biol Sci. 1996;351:233-240; discussion 240-241.
27. Kitajima I, Kawahara K, Nakajima T, Soejima Y, Matsuyama T. Maruyama I. Nitric oxide-mediated apoptosis in murine mastocytoma. Biochem Biophys Res Commun. 1994;204:244-251.
28. Schwartz LM, Osborne BA. Programmed cell death, apoptosis and killer genes. Immunol Today. 1993;14:582-590.
29. Li X-Y, De Marco BM, Mayhew ES, Niederkorn JY. Aqueous humor-borne factor upregulates Bcl-2 expression in corneal endothelial cells. Curr Eye Res. 1998;17:970-978.
30. Weiss A, Wiskocil RL, Stobo JD. The role of T3 surface molecules in the activation of human T cells: a two-stimulus requirement for IL 2 production reflects events occurring at a pre-translational level. J Immunol. 1984;133:123-128.
31. Wilson SE, Weng J, Blair S, He YG, Lloyd S. Expression of E6/E7 or SV40 large T antigen-coding oncogenes in human corneal endothelial cells indicates regulated high-proliferative capacity. Invest Ophthalmol Vis Sci. 1995;36:32-40.
32. He Y-G, Mellon J, Niederkorn JY. The effect of oral immunization on corneal allograft survival. Transplantation 1996;61: 920-926.
33. Streilein JW, Bradley D. Analysis of immunosuppressive properties of iris and ciliary body and their secretory products. Invest Ophthalmol Vis Sci. 1991;32:2700-2710.
34. Charley MR, Mikhael A, Bennett M, Gilliam JN, Sontheimer RD. Prevention of lethal, minor-determinate graft-host disease in mice by the in vivo administration of anti-asialo GM1. J Immunol. 1983;131:2101-2103.
35. Vermes I, Haanen C, Steffens-Nakken H, Reutelingsperger C. A novel assay for apoptosis. Flow cytometric detection of phosphatidylserine expression on early apoptotic cells using fluorescein labelled Annexin V. J Immunol Methods 1995;184:39-51.
36. Martin JS, Reutelingsperger CPM, McGahon AJ. et al. Early redistribution of plasma membrane phosphatidylserine is a general feature of apoptosis regardless of the initiating stimulus: inhibition by overexpression of Bcl-2 and Abl. J Exp Med. 1995;182:1545-1556.
37. Opremcak EM, Whisler RL, Dangel ME. Natural killer cells against human corneal endothelium. Am J Ophthalmol. 1985;99:524-529.
38. Shaughnessy M, Wistow G. Absence of MHC gene expression in lens and cloning of dbpB/YB-1, a DNA -binding protein expressed in mouse lens. Curr Eye Res. 1992;11:175-181.
39. Ljunggren HG, Karre K. In search of the "missing self": MHC molecules and NK cell recognition (see comments). Immunol Today. 1990;11:237-244.
40. Malygin AM, Meri S, Timonen T. Regulation of natural killer cell activity by transforming growth factor-beta and prostaglandin E2. Scand J Immunol. 1993;37:71-76.
41. Apte RS, Niederkorn JY. Isolation and characterization of a unique natural killer cell inhibitory factor present in the anterior chamber of the eye. J Immunol. 1996;156:2667-2673.
42. Wilbanks GA, Streilein JW. Studies on the induction of anterior chamber-associated immune deviation (ACAID), I: evidence that an antigen-specific, ACAID-inducing, cell-associated signal exists in the peripheral blood. J Immunol. 1991;146:2610-2617.
43. Wilbanks GA, Mammolenti M, Streilein JW. Studies on the induction of anterior chamber-associated immune deviation (ACAID), II: eye-derived cells participate in generating blood-borne signals that induce ACAID. J Immunol. 1991;146:3018-3024.
44. Chen J, Flannery JG, LaVail MM, Steinberg RH, Xu J, Simon MI. Bcl-2 over expression reduces apoptotic photoreceptor cell death in three different retinal degenerations. Proc Natl Acad Sci USA. 1996;93:7042-7047.
45. Reed JC. Bcl-2 and the regulation of programmed cell death. J Cell Biol. 1994;124:1-6.
46. Oltvai ZN, Milliman CL, Korsmeyer SJ. Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death. Cell. 1993;74:609-619.
47. Yamagami S, Kawashima H, Tsuru T, et al. Role of Fas-Fas ligand interactions in the immunorejection of allogeneic mouse corneal transplants. Transplantation. 1997;64:1107-1111.
48. Streilein JW, McCulley J, Niederkorn JY. Heterotopic corneal grafting in mice: a new approach to the study of corneal alloimmunity. Invest Ophthalmol Vis Sci. 1982;23:489-500.